
20,000,000 U.S. men have enlarged prostates and need diagnosis.
The CT3000 provides the first non-invasive diagnosis of prostate problems that can: (1) accurately identify good surgical candidates and (2) provide an objective basis for managing Flomax and similar medications. Many men who have been reluctant to undergo the catheterization necessary for conventional urodynamics can now be tested quickly and comfortably.
High Performance Male Bladder Analysis
The CT3000 is designed to help identify those patients that have good bladder pressure, yet suffer from Bladder Outlet Obstruction (BOO). This group of patients is known to demonstrate improvement following TURP. Studies have shown that its 87% success rate in predicting good surgical candidates is similar to that achieved by invasive urodynamics (range 79–93%).
Fast, accurate, reliable testing
The CT3000 uses a method similar to that for blood pressure measurement. A penile cuff (far left) is fitted to the patient who is then asked to void in the normal way. An estimate of isovolumetric bladder pressure (Pcuff.int) and a measurement of maximum flow rate (Qmax.cuff) are obtained and plotted on a nomogram to allow categorization into obstructed, not obstructed, or “diagnosis uncertain” groups. Click here to view a summary report.
Invest in the future
In addition to providing the first clinically proven test for non-invasive voiding pressure right now, as part of the Clarity™ uDx platform, the CT3000 provides you with a flexible upgrade path. Options include: